
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Nina G. Steele, Giulia Biffi, Samantha B. Kemp, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 7, pp. 2023-2037
Open Access | Times Cited: 213
Nina G. Steele, Giulia Biffi, Samantha B. Kemp, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 7, pp. 2023-2037
Open Access | Times Cited: 213
Showing 1-25 of 213 citing articles:
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Pancreatic Cancer: Pathogenesis, Screening, Diagnosis, and Treatment
Laura D. Wood, Marcia I. Canto, Elizabeth M. Jaffee, et al.
Gastroenterology (2022) Vol. 163, Iss. 2, pp. 386-402.e1
Open Access | Times Cited: 488
Laura D. Wood, Marcia I. Canto, Elizabeth M. Jaffee, et al.
Gastroenterology (2022) Vol. 163, Iss. 2, pp. 386-402.e1
Open Access | Times Cited: 488
Cancer-associated fibroblasts in the single-cell era
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 337
Dor Lavie, Aviad Ben‐Shmuel, Neta Erez, et al.
Nature Cancer (2022) Vol. 3, Iss. 7, pp. 793-807
Open Access | Times Cited: 337
Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Mara H. Sherman, Gregory L. Beatty
Annual Review of Pathology Mechanisms of Disease (2022) Vol. 18, Iss. 1, pp. 123-148
Open Access | Times Cited: 206
Translational advances in pancreatic ductal adenocarcinoma therapy
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 176
Abdel Hosein, Stephanie K. Dougan, Andrew J. Aguirre, et al.
Nature Cancer (2022) Vol. 3, Iss. 3, pp. 272-286
Open Access | Times Cited: 176
The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 174
Paris Jabeen Asif, Ciro Longobardi, Michael Hahne, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4720-4720
Open Access | Times Cited: 174
Activated fibroblasts in cancer: Perspectives and challenges
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 165
Giuseppina Caligiuri, David A. Tuveson
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 434-449
Open Access | Times Cited: 165
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 141
Raisa A. Glabman, Peter L. Choyke, Noriko Sato
Cancers (2022) Vol. 14, Iss. 16, pp. 3906-3906
Open Access | Times Cited: 141
Cancer-Associated Fibroblast (CAF) Heterogeneity and Targeting Therapy of CAFs in Pancreatic Cancer
Xinglong Geng, Hongze Chen, Liang Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
Xinglong Geng, Hongze Chen, Liang Zhao, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 138
Signaling pathways in cancer‐associated fibroblasts: recent advances and future perspectives
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Zengli Fang, Qingcai Meng, Jin Xu, et al.
Cancer Communications (2022) Vol. 43, Iss. 1, pp. 3-41
Open Access | Times Cited: 133
Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin
Deshka S. Foster, Michael Januszyk, Daniel Delitto, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1392-1406.e7
Open Access | Times Cited: 126
Deshka S. Foster, Michael Januszyk, Daniel Delitto, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1392-1406.e7
Open Access | Times Cited: 126
Combined MEK and STAT3 Inhibition Uncovers Stromal Plasticity by Enriching for Cancer-Associated Fibroblasts With Mesenchymal Stem Cell-Like Features to Overcome Immunotherapy Resistance in Pancreatic Cancer
Jashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Gastroenterology (2022) Vol. 163, Iss. 6, pp. 1593-1612
Open Access | Times Cited: 105
Jashodeep Datta, Xizi Dai, Anna Bianchi, et al.
Gastroenterology (2022) Vol. 163, Iss. 6, pp. 1593-1612
Open Access | Times Cited: 105
Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 96
Tianyi Zhang, Yanxian Ren, Pengfei Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 10
Open Access | Times Cited: 96
Cellular senescence and the tumour microenvironment
Masaki Takasugi, Yuya Yoshida, Naoko Ohtani
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3333-3351
Open Access | Times Cited: 95
Masaki Takasugi, Yuya Yoshida, Naoko Ohtani
Molecular Oncology (2022) Vol. 16, Iss. 18, pp. 3333-3351
Open Access | Times Cited: 95
The heterogeneity of cancer‐associated fibroblast subpopulations: Their origins, biomarkers, and roles in the tumor microenvironment
Yurie Yamamoto, Hiroaki Kasashima, Yasuhiro Fukui, et al.
Cancer Science (2022) Vol. 114, Iss. 1, pp. 16-24
Open Access | Times Cited: 70
Yurie Yamamoto, Hiroaki Kasashima, Yasuhiro Fukui, et al.
Cancer Science (2022) Vol. 114, Iss. 1, pp. 16-24
Open Access | Times Cited: 70
Cancer-associated fibroblasts: The chief architect in the tumor microenvironment
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 68
Mrinmoy Sarkar, Tristan Nguyen, Esheksha Gundre, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 68
EGFR-activated myofibroblasts promote metastasis of pancreatic cancer
Gianluca Mucciolo, Joaquín Araos Henríquez, Muntadher Jihad, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 101-118.e11
Open Access | Times Cited: 66
Gianluca Mucciolo, Joaquín Araos Henríquez, Muntadher Jihad, et al.
Cancer Cell (2023) Vol. 42, Iss. 1, pp. 101-118.e11
Open Access | Times Cited: 66
Single-cell profiling to explore pancreatic cancer heterogeneity, plasticity and response to therapy
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 454-467
Open Access | Times Cited: 50
Stefanie Bärthel, Chiara Falcomatà, Roland Rad, et al.
Nature Cancer (2023) Vol. 4, Iss. 4, pp. 454-467
Open Access | Times Cited: 50
Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Moumita Kundu, Ramesh Butti, Venketesh K. Panda, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 44
Current and future immunotherapeutic approaches in pancreatic cancer treatment
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Pooya Farhangnia, Hossein Khorramdelazad, Hamid Nickho, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 29
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 29
Pancreatic cancer tumor microenvironment is a major therapeutic barrier and target
Conner Hartupee, Bolni Marius Nagalo, Chiswili Chabu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 25
Conner Hartupee, Bolni Marius Nagalo, Chiswili Chabu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 25
Tumor immune microenvironment-based therapies in pancreatic ductal adenocarcinoma: time to update the concept
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Wenyu Luo, Ti Wen, Xiujuan Qu
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 24
Distinct fibroblast subpopulations associated with bone, brain or intrapulmonary metastasis in advanced non‐small‐cell lung cancer
Ke Xu, Hao Wang, Yu‐Xia Zou, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Ke Xu, Hao Wang, Yu‐Xia Zou, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 3
Open Access | Times Cited: 16